doi: 10.1038/nrgastro.2016.107 166 RebosioC.BalbiM.PassalacquaM.RicciarelliR.FedeleE
Stay Informed: Bookmark MOAAs advocacy news page for the latest on this issue and others, and be sure youve registered at our Legislative Action Center so you can receive updates from our advocacy team
We will help you plan for the long term goals.
This documentation serves multiple purposes
As many as 1 in every 8 Americans have used medications like semaglutide (Ozempic, Wegovy) for weight loss

Wegovy (Novo Nordisk) Patient Support Program Eligibility: Must have private insurance that covers Wegovy, not receiving government drug benefits Savings: Up to $150 per monthly prescription for 12 months Maximum annual benefit: $1,800 How it works: Reduces out-of-pocket costs after insurance pays their portion Saxenda (Novo Nordisk) Patient Support Program Eligibility: Private insurance covering Saxenda, not on provincial drug plans Savings: Up to $120 per monthly prescription Maximum annual benefit: $1,440 How it works: Applied at pharmacy, reduces copay amount Expected Retatrutide Program (Not Yet Announced) Projected eligibility: Private insurance with Retatrutide coverage, not receiving provincial benefits Projected savings: $200-300 per monthly prescription based on medication cost Projected maximum benefit: $2,400-3,600 annually Expected launch: Same time as Health Canada approval The catch with Canadian savings programs: you need private insurance that already covers the medication
